Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Johnson

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Leukemia|July 3, 2013
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptomsBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
Blood|July 10, 2010
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBrian A Walker, Paola E Leone, Laura Chiecchio, et al.
The Journal of Urology|May 8, 2024
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective StudyAmir Feinberg, Kathryn H Gessner, Allison M Deal, et al.
Leukemia|March 12, 2020
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patientsVallari Shah, Amy L Sherborne, David C Johnson, et al.
Blood|September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotypingDavid C Johnson, Sophie Corthals, Christine Ramos, et al.
Blood|July 5, 2007
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaMatthew W Jenner, Paola E Leone, Brian A Walker, et al.
Oncogene|January 11, 2019
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitationKatarzyna Parzych, Paula Saavedra-García, Gabriel N Valbuena, et al.
Blood|November 18, 2018
The genomic landscape of plasma cells in systemic light chain amyloidosisEileen M Boyle, Cody Ashby, Christopher P Wardell, et al.
Nature Communications|January 9, 2016
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myelomaDavid C Johnson, Niels Weinhold, Jonathan S Mitchell, et al.
Nature Communications|April 24, 2015
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myelomaBrian A Walker, Christopher P Wardell, Alex Murison, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Leukemia|July 3, 2013
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptomsBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
Blood|July 10, 2010
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBrian A Walker, Paola E Leone, Laura Chiecchio, et al.
The Journal of Urology|May 8, 2024
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective StudyAmir Feinberg, Kathryn H Gessner, Allison M Deal, et al.
Leukemia|March 12, 2020
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patientsVallari Shah, Amy L Sherborne, David C Johnson, et al.
Blood|September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotypingDavid C Johnson, Sophie Corthals, Christine Ramos, et al.
Blood|July 5, 2007
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaMatthew W Jenner, Paola E Leone, Brian A Walker, et al.
Oncogene|January 11, 2019
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitationKatarzyna Parzych, Paula Saavedra-García, Gabriel N Valbuena, et al.
Blood|November 18, 2018
The genomic landscape of plasma cells in systemic light chain amyloidosisEileen M Boyle, Cody Ashby, Christopher P Wardell, et al.
Nature Communications|January 9, 2016
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myelomaDavid C Johnson, Niels Weinhold, Jonathan S Mitchell, et al.
Nature Communications|April 24, 2015
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myelomaBrian A Walker, Christopher P Wardell, Alex Murison, et al.
Pageof 25